ArticleCancer management and research2020

Progastrin-Releasing Peptide Precursor and Neuron-Specific Enolase Predict the Efficacy of First-Line Treatment with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Among Non-Small-Cell Lung Cancer Patients Harboring EGFR Mutations.

Juanjuan Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.